NEFH and Guillain-Barre syndrome: Although neurofilament heavy (NfH) was described as an axonal biomarker well before NfL and early studies of small numbers of patients showed that higher CSF levels predict axonal involvement and poor outcome in GBS [11–13], it has not been as extensively studied.